Please use this identifier to cite or link to this item:
|Title:||Compulsory Licensing under Section 92A: Issues and Concerns|
|Keywords:||Patents;TRIPS;Compulsory licensing;Section 92A, arbitrage;R & D|
|Abstract:||As the patents laws continually soar in dynamic transition, burning controversy that rages up is compulsory licensing under Section 92A of the Indian Patents Act enabling exportation of patented drugs. This dissertation is a research-based factual analysis of patents as a real barrier to the accessibility to drugs and the extent to which compulsory licensing remodels the situation, in reference to the latest legal development- Natco v Pfizer which has hauled the key provisions before the legal eye for severe scrutiny. This paper is an endeavour to analyse the issue of patents v patients in the light of a possible outcome of this potentially landmark case.|
|Appears in Collections:||JIPR Vol.13(5) [September 2008]|
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.